These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10462228)

  • 1. Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age.
    Viviani S; Jack A; Hall AJ; Maine N; Mendy M; Montesano R; Whittle HC
    Vaccine; 1999 Aug; 17(23-24):2946-50. PubMed ID: 10462228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
    Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
    Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.
    Fortuin M; Chotard J; Jack AD; Maine NP; Mendy M; Hall AJ; Inskip HM; George MO; Whittle HC
    Lancet; 1993 May; 341(8853):1129-31. PubMed ID: 8097813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
    Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
    Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program.
    Peto TJ; Mendy ME; Lowe Y; Webb EL; Whittle HC; Hall AJ
    BMC Infect Dis; 2014 Jan; 14():7. PubMed ID: 24397793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term protection against carriage of hepatitis B virus after infant vaccination.
    van der Sande MA; Waight P; Mendy M; Rayco-Solon P; Hutt P; Fulford T; Doherty C; McConkey SJ; Jeffries D; Hall AJ; Whittle HC
    J Infect Dis; 2006 Jun; 193(11):1528-35. PubMed ID: 16652281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia.
    Whittle HC; Inskip H; Hall AJ; Mendy M; Downes R; Hoare S
    Lancet; 1991 Mar; 337(8744):747-50. PubMed ID: 1672389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hepatitis B vaccination on HBV-infection among school children in Yaounde; ten years after the introduction of HBV vaccine into routine Immunization Program in Cameroon.
    Nguwoh PS; Ngounouh CT; Essomba RG; Olinga PZ; Likeng JLN; Nguepidjo G; Douyong SCT; Tchoffo D; Nlend AEN; Assoumou MCO; Fokam J
    Pan Afr Med J; 2024; 47():169. PubMed ID: 39036018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
    He F; Ma YJ; Zhou TY; Duan JC; Wang JF; Ji YL; Li H; Zhang JY; Tang H
    Viral Immunol; 2016; 29(1):40-8. PubMed ID: 26565951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of hepatitis-B vaccination in Ivory Coast: the case of the Grand Bassam health district.
    Magoni M; Ekra KD; Aka LN; Sita KS; Kanga K
    Ann Trop Med Parasitol; 2009 Sep; 103(6):519-27. PubMed ID: 19695157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence.
    van der Sande MA; Waight PA; Mendy M; Zaman S; Kaye S; Sam O; Kahn A; Jeffries D; Akum AA; Hall AJ; Bah E; McConkey SJ; Hainaut P; Whittle HC
    PLoS One; 2007 Aug; 2(8):e753. PubMed ID: 17710152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B infection awareness, vaccine perceptions and uptake, and serological profile of a group of health care workers in Yaoundé, Cameroon.
    Tatsilong HO; Noubiap JJ; Nansseu JR; Aminde LN; Bigna JJ; Ndze VN; Moyou RS
    BMC Public Health; 2016 Aug; 15():706. PubMed ID: 27487845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
    de la Hoz F; Perez L; de Neira M; Hall AJ
    Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBV immunization and vaccine coverage among hospitalized children in Cameroon, Central African Republic and Senegal: a cross-sectional study.
    Bekondi C; Zanchi R; Seck A; Garin B; Giles-Vernick T; Gody JC; Bata P; Pondy A; Tetang SM; Ba M; Ekobo CS; Rousset D; Sire JM; Maylin S; Chartier L; Njouom R; Vray M
    BMC Infect Dis; 2015 Jul; 15():267. PubMed ID: 26164361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus markers among teenagers in the Araguaia region, Central Brazil: assessment of prevalence and vaccination coverage.
    Melo LV; da Silva MA; Calçada Cde O; Cavalcante SR; Souto FJ
    Vaccine; 2011 Jul; 29(32):5290-3. PubMed ID: 21605613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of antibodies to the surface antigen of the hepatitis B virus (anti-HBs) in children subjected to the Expanded Programme on Immunization (EPI), including hepatitis-B vaccine, in Thailand.
    Poovorawan Y; Theamboonlers A; Hirsch P; Vimolket T; Sinlaparatsamee S; Chaiear K; Siraprapasiri T; Khwanjaipanich S; Owatanapanich S; Chunsuttiwat S
    Ann Trop Med Parasitol; 2000 Sep; 94(6):615-21. PubMed ID: 11064763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.